SHAREHOLDERS' EQUITY - Narrative (Details)						3 Months Ended		52 Months Ended
	Apr. 26, 2023 shares	Nov. 17, 2022 USD ($) $ / shares shares	Jul. 18, 2021	Feb. 04, 2020 USD ($) sales_agent	Jul. 18, 2011	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Aug. 02, 2022 USD ($)	Aug. 01, 2022 USD ($)	Aug. 31, 2021 USD ($)	Jul. 28, 2021 USD ($)	May 26, 2021 USD ($)	Mar. 04, 2019 USD ($)
Subsidiary or Equity Method Investee [Line Items]
Repurchase authorized amount											$ 20,000,000	$ 20,000,000
Cancellation of treasury stock (in shares) | shares	2,339,512
Public Equity Offering
Subsidiary or Equity Method Investee [Line Items]
Number of shares sold (in shares) | shares		2,534,436
Par value, common stock (in usd per share) | $ / shares		$ 18.15
Gross proceeds received (in thousands)		$ 46,000,000
Net proceeds received		$ 44,100,000
Equity ATM Program
Subsidiary or Equity Method Investee [Line Items]
Number of shares sold (in shares) | shares						2,527,458	2,262,852	19,140,580
Gross proceeds received (in thousands)						$ 45,572,000	$ 46,753,000	$ 390,300,000
Net proceeds received						$ 44,888,000	$ 46,052,000	$ 384,000,000
Maximum consideration threshold				$ 100,000,000					$ 650,000,000	$ 250,000,000			$ 250,000,000	$ 50,000,000
Number of additional sales agents | sales_agent				2
Gross sales commission percentage													1.50%	2.00%
Weighted average price per share (in usd per share) | $ / shares						$ 18.03	$ 20.66	$ 20.39
Available under the Equity ATM Program						$ 259,700,000		$ 259,700,000
2010 Plan | Restricted Stock
Subsidiary or Equity Method Investee [Line Items]
Right to grant period			10 years		10 years